UQCC5
gene geneOn this page
Summary
UQCC5 (ubiquinol-cytochrome c reductase complex assembly factor 5, HGNC:37257) is a protein-coding gene on chromosome 3p21.1, encoding Ubiquinol-cytochrome c reductase complex assembly factor 5 (Q8WVI0). Required for the assembly and stability of the mitochondrial ubiquinol-cytochrome c reductase complex (complex III (CIII) or cytochrome b-c1 complex), a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain (ETC) which drives oxidative pho….
Enables mitochondrial ribosome binding activity. Involved in mitochondrial cytochrome c oxidase assembly. Located in mitochondrion. Is active in mitochondrial inner membrane.
Source: NCBI Gene 440957 — RefSeq curated summary.
At a glance
- GWAS associations: 17
- Clinical variants (ClinVar): 14 total
- MANE Select transcript:
NM_001124767
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:37257 |
| Approved symbol | UQCC5 |
| Name | ubiquinol-cytochrome c reductase complex assembly factor 5 |
| Location | 3p21.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000168273 |
| Ensembl biotype | protein_coding |
| OMIM | 620435 |
| Entrez | 440957 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000307106, ENST00000476842, ENST00000477703, ENST00000482728, ENST00000491607, ENST00000916170
RefSeq mRNA: 1 — MANE Select: NM_001124767
NM_001124767
CCDS: CCDS46844
Canonical transcript exons
ENST00000477703 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001285599 | 52536605 | 52536906 |
| ENSE00001954171 | 52540424 | 52541890 |
Expression profiles
Bgee: expression breadth ubiquitous, 198 present calls, max score 97.37.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 80.6558 / max 814.9422, expressed in 1822 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 36877 | 62.6193 | 1819 |
| 36882 | 6.7637 | 1710 |
| 36879 | 5.8160 | 1723 |
| 36881 | 2.4388 | 1433 |
| 36876 | 1.6946 | 930 |
| 36878 | 0.9808 | 623 |
| 36880 | 0.3425 | 149 |
Top tissues by expression
237 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left adrenal gland cortex | UBERON:0035825 | 97.37 | gold quality |
| left adrenal gland | UBERON:0001234 | 97.07 | gold quality |
| right adrenal gland | UBERON:0001233 | 96.68 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 96.42 | gold quality |
| adenohypophysis | UBERON:0002196 | 95.94 | gold quality |
| apex of heart | UBERON:0002098 | 95.89 | gold quality |
| right atrium auricular region | UBERON:0006631 | 95.52 | gold quality |
| adrenal cortex | UBERON:0001235 | 95.49 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.44 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 94.96 | gold quality |
| adrenal gland | UBERON:0002369 | 94.82 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 94.75 | gold quality |
| heart left ventricle | UBERON:0002084 | 94.11 | gold quality |
| cardiac atrium | UBERON:0002081 | 93.80 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 93.54 | gold quality |
| muscle of leg | UBERON:0001383 | 93.54 | gold quality |
| cardiac ventricle | UBERON:0002082 | 93.47 | gold quality |
| gastrocnemius | UBERON:0001388 | 93.43 | gold quality |
| pituitary gland | UBERON:0000007 | 93.14 | gold quality |
| thyroid gland | UBERON:0002046 | 93.01 | gold quality |
| heart | UBERON:0000948 | 92.53 | gold quality |
| left ovary | UBERON:0002119 | 92.49 | gold quality |
| metanephros cortex | UBERON:0010533 | 91.47 | gold quality |
| right ovary | UBERON:0002118 | 90.75 | gold quality |
| left coronary artery | UBERON:0001626 | 90.23 | gold quality |
| mucosa of stomach | UBERON:0001199 | 90.19 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 89.45 | gold quality |
| lower esophagus | UBERON:0013473 | 89.41 | gold quality |
| right coronary artery | UBERON:0001625 | 89.26 | gold quality |
| endocervix | UBERON:0000458 | 88.68 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-11 | yes | 93.72 |
| E-ANND-3 | yes | 15.74 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- Defining the interactome of the human mitochondrial ribosome identifies SMIM4 and TMEM223 as respiratory chain assembly factors. (PMID:34969438)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | uqcc5 | ENSDARG00000089921 |
| mus_musculus | Uqcc5 | ENSMUSG00000058351 |
| rattus_norvegicus | Uqcc5 | ENSRNOG00000068020 |
| drosophila_melanogaster | sloth1 | FBGN0052736 |
Protein
Protein identifiers
Ubiquinol-cytochrome c reductase complex assembly factor 5 — Q8WVI0 (reviewed: Q8WVI0)
Alternative names: Small integral membrane protein 4
All UniProt accessions (3): C9JAX8, Q8WVI0, F8W7Q2
UniProt curated annotations — full annotation on UniProt →
Function. Required for the assembly and stability of the mitochondrial ubiquinol-cytochrome c reductase complex (complex III (CIII) or cytochrome b-c1 complex), a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain (ETC) which drives oxidative phosphorylation. Mediates early complex III biogenesis. Participates in regulating the levels of electron transport chain proteins, and therefore energy supply, in response to changes in energy demand. Also involved in the first steps of cytochrome c oxidase complex (complex IV) assembly.
Subunit / interactions. Associates with the mitochondrial ribosome. Interacts with UQCC6. Interacts with MT-CYB; interacts with newly synthesizes MT-CYB. Forms a complex, named COMB/coordinator of mitochondrial CYTB biogenesis, composed of UQCC1, UQCC2, UQCC4, UQCC5 and UQCC6; regulates MT-CYB synthesis and promotes its membrane insertion.
Subcellular location. Mitochondrion inner membrane.
Similarity. Belongs to the UQCC5 family.
RefSeq proteins (1): NP_001118239* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR028183 | UQCC5 | Family |
Pfam: PF15114
UniProt features (4 total): topological domain 2, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WVI0-F1 | 68.34 | 0.07 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9865881 | Complex III assembly |
MSigDB gene sets: 0 (showing top):
GO Biological Process (2): mitochondrial respiratory chain complex IV assembly (GO:0033617), mitochondrial respiratory chain complex III assembly (GO:0034551)
GO Molecular Function (1): mitochondrial ribosome binding (GO:0097177)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 2 |
| mitochondrial respiratory chain complex assembly | 2 |
| respiratory chain complex IV assembly | 1 |
| respiratory chain complex III assembly | 1 |
| ribosome binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
390 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| UQCC5 | TMEM223 | A0PJW6 | 577 |
| UQCC5 | NT5DC2 | Q9H857 | 511 |
| UQCC5 | OXA1L | Q15070 | 494 |
| UQCC5 | MAGED2 | Q9UNF1 | 477 |
| UQCC5 | P4HTM | Q9NXG6 | 475 |
| UQCC5 | AGR2 | O95994 | 444 |
| UQCC5 | INPP4B | O15327 | 444 |
| UQCC5 | GTPBP10 | A4D1E9 | 443 |
| UQCC5 | MALSU1 | Q96EH3 | 437 |
| UQCC5 | UQCC1 | Q9NVA1 | 431 |
| UQCC5 | UQCC6 | Q69YU5 | 420 |
| UQCC5 | MRM3 | Q9HC36 | 414 |
| UQCC5 | DDX28 | Q9NUL7 | 413 |
| UQCC5 | MCMDC2 | Q4G0Z9 | 406 |
| UQCC5 | TIMMDC1 | Q9NPL8 | 399 |
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HSCB | RBP5 | psi-mi:“MI:0914”(association) | 0.350 |
| AFG2A | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| ATF2 | PLOD2 | psi-mi:“MI:0914”(association) | 0.350 |
| MYC | AP3B1 | psi-mi:“MI:0914”(association) | 0.350 |
| STAT3 | IDH3B | psi-mi:“MI:0914”(association) | 0.350 |
| CASP3 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| FOS | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| GATA2 | C11orf98 | psi-mi:“MI:0914”(association) | 0.350 |
| ATF3 | C11orf98 | psi-mi:“MI:0914”(association) | 0.350 |
| CASP3 | NACA | psi-mi:“MI:0914”(association) | 0.350 |
| CTNNA1 | KIF2A | psi-mi:“MI:0914”(association) | 0.350 |
| ERBB2 | AP3B1 | psi-mi:“MI:0914”(association) | 0.350 |
| FOS | C11orf98 | psi-mi:“MI:0914”(association) | 0.350 |
| ERBB2 | AGPS | psi-mi:“MI:0914”(association) | 0.350 |
| STAT3 | NACA | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (7): SMIM4 (Affinity Capture-MS), SMIM4 (Affinity Capture-MS), SMIM4 (Affinity Capture-MS), SMIM4 (Affinity Capture-MS), SMIM4 (Affinity Capture-MS), SMIM4 (Cross-Linking-MS (XL-MS)), SMIM4 (Affinity Capture-RNA)
ESM2 similar proteins: A1L2P2, A2VDV9, A5PJ82, D2H617, D3Z9R8, D4ACP2, E2R5I0, E7EXZ6, F6USH3, G1QDE8, G1S9B8, O00483, O95298, P11951, P14790, P56378, P56379, Q0MQ97, Q0MQ98, Q0MQ99, Q0MQF7, Q0MQF8, Q0MQF9, Q0Q4Z0, Q28EM2, Q28GF4, Q2NKS2, Q4FZG9, Q502E5, Q5BKW8, Q5RCY6, Q5RDZ8, Q5REX0, Q62425, Q68EV8, Q69YU5, Q78IK2, Q78RX3, Q7YRJ8, Q7YRK7
Diamond homologs: Q8C1Q6, Q8WVI0, Q9W3T5
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 21 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| positive regulation of gene expression | 5 | 9.7× | 7e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
14 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 13 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1970 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 3:52536907:G:GG | donor_gain | 1.0000 |
| 3:52548231:TCGAG:T | acceptor_gain | 1.0000 |
| 3:52548232:CGAG:C | acceptor_gain | 1.0000 |
| 3:52548232:CGAGC:C | acceptor_gain | 1.0000 |
| 3:52548233:GAG:G | acceptor_gain | 1.0000 |
| 3:52548234:AG:A | acceptor_gain | 1.0000 |
| 3:52548236:C:CC | acceptor_gain | 1.0000 |
| 3:52548236:CTGA:C | acceptor_loss | 1.0000 |
| 3:52548242:A:AC | acceptor_gain | 1.0000 |
| 3:52548242:A:C | acceptor_gain | 1.0000 |
| 3:52548243:T:C | acceptor_gain | 1.0000 |
| 3:52548243:T:TC | acceptor_gain | 1.0000 |
| 3:52548248:G:C | acceptor_gain | 1.0000 |
| 3:52548248:G:GC | acceptor_gain | 1.0000 |
| 3:52550415:TCTTA:T | donor_loss | 1.0000 |
| 3:52550416:CTTA:C | donor_loss | 1.0000 |
| 3:52550417:TTACC:T | donor_loss | 1.0000 |
| 3:52550418:TACC:T | donor_loss | 1.0000 |
| 3:52550419:A:AC | donor_gain | 1.0000 |
| 3:52550419:ACCT:A | donor_loss | 1.0000 |
| 3:52550419:ACCTG:A | donor_gain | 1.0000 |
| 3:52550420:C:CC | donor_gain | 1.0000 |
| 3:52550420:C:CT | donor_loss | 1.0000 |
| 3:52550420:CCTG:C | donor_gain | 1.0000 |
| 3:52550420:CCTGC:C | donor_gain | 1.0000 |
| 3:52550635:CACCT:C | acceptor_loss | 1.0000 |
| 3:52550637:CCTGA:C | acceptor_loss | 1.0000 |
| 3:52550639:T:G | acceptor_loss | 1.0000 |
| 3:52550814:ACACC:A | acceptor_loss | 1.0000 |
| 3:52550815:CAC:C | acceptor_gain | 1.0000 |
AlphaMissense
446 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 3:52536875:G:A | M40I | 0.992 |
| 3:52536875:G:C | M40I | 0.992 |
| 3:52536875:G:T | M40I | 0.992 |
| 3:52536903:T:C | F50L | 0.992 |
| 3:52536905:C:A | F50L | 0.992 |
| 3:52536905:C:G | F50L | 0.992 |
| 3:52540436:G:C | R55P | 0.987 |
| 3:52540440:A:C | R56S | 0.982 |
| 3:52540440:A:T | R56S | 0.982 |
| 3:52536866:G:C | E37D | 0.979 |
| 3:52536866:G:T | E37D | 0.979 |
| 3:52536853:G:A | G33E | 0.978 |
| 3:52536904:T:G | F50C | 0.976 |
| 3:52536852:G:A | G33R | 0.974 |
| 3:52536852:G:C | G33R | 0.974 |
| 3:52536847:T:A | V31D | 0.972 |
| 3:52536856:G:A | G34E | 0.972 |
| 3:52536904:T:C | F50S | 0.971 |
| 3:52540439:G:C | R56T | 0.971 |
| 3:52536832:T:G | L26R | 0.970 |
| 3:52536865:A:T | E37V | 0.967 |
| 3:52536901:C:T | T49I | 0.967 |
| 3:52540435:C:A | R55S | 0.967 |
| 3:52536864:G:A | E37K | 0.964 |
| 3:52536867:T:A | W38R | 0.962 |
| 3:52536867:T:C | W38R | 0.962 |
| 3:52536835:C:G | P27R | 0.961 |
| 3:52536855:G:A | G34R | 0.961 |
| 3:52536855:G:C | G34R | 0.961 |
| 3:52536877:T:C | I41T | 0.961 |
dbSNP variants (sampled 300 via entrez): RS1000039280 (3:52536808 A>G), RS1000051190 (3:52537691 G>A), RS1000151301 (3:52537912 C>G), RS1001108182 (3:52539324 C>T), RS1001322787 (3:52537550 A>G), RS1002174375 (3:52537324 G>A), RS1002267647 (3:52537631 G>A), RS1002394953 (3:52538670 A>G), RS1002599940 (3:52539333 C>T), RS1002734126 (3:52538965 C>G,T), RS1003880542 (3:52540193 A>C,G), RS1004162234 (3:52539879 C>T), RS1004175265 (3:52535277 A>T), RS1004227702 (3:52535569 A>G), RS1004283767 (3:52541983 T>C,G)
Disease associations
OMIM: gene MIM:620435 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
17 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002149_14 | Schizophrenia | 1.000000e-08 |
| GCST002539_48 | Schizophrenia | 4.000000e-11 |
| GCST004521_123 | Autism spectrum disorder or schizophrenia | 3.000000e-12 |
| GCST004521_201 | Autism spectrum disorder or schizophrenia | 4.000000e-08 |
| GCST004521_259 | Autism spectrum disorder or schizophrenia | 6.000000e-09 |
| GCST005316_399 | Intelligence (MTAG) | 1.000000e-08 |
| GCST006803_55 | Schizophrenia | 1.000000e-11 |
| GCST008103_3 | Bipolar disorder | 7.000000e-11 |
| GCST010698_14 | Subcortical volume (min-P) | 8.000000e-09 |
| GCST010699_73 | Brain morphology (min-P) | 1.000000e-18 |
| GCST010701_137 | Cortical surface area (MOSTest) | 8.000000e-10 |
| GCST010702_70 | Subcortical volume (MOSTest) | 2.000000e-11 |
| GCST010703_327 | Brain morphology (MOSTest) | 1.000000e-10 |
| GCST012228_63 | Waist-hip index | 5.000000e-11 |
| GCST012230_260 | Waist-to-hip ratio adjusted for BMI | 6.000000e-10 |
| GCST90020025_1342 | Waist-to-hip ratio adjusted for BMI | 5.000000e-13 |
| GCST90020027_124 | Waist-hip index | 1.000000e-13 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
| EFO:0004346 | neuroimaging measurement |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, increases methylation | 2 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| beta-lapachone | decreases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| ICG 001 | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Hydrogen Peroxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Acrylamide | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B2GP | Abcam HeLa SMIM4 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.